GREB1 and breast carcinoma: PR and GREB1, two genes commonly associated with estrogen responsiveness in breast cancer, are not included in the signature because their expression levels were significantly reduced by H2O2 and menadione treatments but not significantly reduced by the thiol-specific oxidant diamide.